Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | casein kinase II, putative | 0.0392 | 0.9976 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Schistosoma mansoni | protein kinase | 0.0392 | 0.9976 | 0.9976 |
Giardia lamblia | Kinase, CMGC GSK | 0.0114 | 0.1785 | 0.1789 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0114 | 0.1785 | 0.1785 |
Echinococcus granulosus | protein kinase shaggy | 0.0114 | 0.1785 | 0.1785 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0114 | 0.1785 | 0.1785 |
Entamoeba histolytica | casein kinase, putative | 0.0392 | 0.9976 | 0.9976 |
Giardia lamblia | Kinase, CMGC GSK | 0.0114 | 0.1785 | 0.1789 |
Giardia lamblia | Kinase, CMGC CK2 | 0.0392 | 0.9976 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0392 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.0392 | 0.9976 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.0392 | 0.9976 | 1 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.0392 | 0.9976 | 0.9976 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0114 | 0.1785 | 0.1789 |
Echinococcus multilocularis | homeodomain interacting protein kinase 3 | 0.0392 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Leishmania major | casein kinase II, putative | 0.0392 | 0.9976 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0114 | 0.1785 | 0.1785 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.0392 | 0.9976 | 1 |
Onchocerca volvulus | 0.0114 | 0.1785 | 0.5 | |
Echinococcus multilocularis | protein kinase shaggy | 0.0114 | 0.1785 | 0.1785 |
Loa Loa (eye worm) | CMGC/DYRK/HIPK protein kinase | 0.0392 | 1 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0114 | 0.1785 | 0.1785 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0392 | 0.9976 | 0.9976 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0114 | 0.1785 | 0.1789 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0114 | 0.1785 | 0.1789 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0114 | 0.1785 | 0.1789 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0114 | 0.1785 | 0.1785 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0114 | 0.1785 | 0.1785 |
Trypanosoma brucei | protein kinase, putative | 0.0114 | 0.1785 | 0.1789 |
Brugia malayi | intracellular kinase | 0.0114 | 0.1785 | 0.1785 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0114 | 0.1785 | 0.1789 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.0392 | 0.9976 | 0.9976 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0392 | 1 | 1 |
Trypanosoma brucei | Casein kinase II | 0.0392 | 0.9976 | 1 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.0392 | 0.9976 | 0.9976 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0114 | 0.1785 | 0.1789 |
Echinococcus granulosus | homeodomain interacting protein kinase 3 | 0.0392 | 1 | 1 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0114 | 0.1785 | 0.1789 |
Entamoeba histolytica | protein kinase, putative | 0.0114 | 0.1785 | 0.1785 |
Plasmodium vivax | unspecified product | 0.0392 | 0.9976 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0392 | 0.9976 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0114 | 0.1785 | 0.1785 |
Brugia malayi | Casein kinase II, alpha chain | 0.0392 | 0.9976 | 0.9976 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.